RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
RETA
Delisted
RETA was delisted on the 25th of September, 2023.
168 hedge funds and large institutions have $1.14B invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2022 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 55 increasing their positions, 44 reducing their positions, and 25 closing their positions.
Holders
168
Holders Change
+9
Holders Change %
+5.66%
% of All Funds
2.71%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
36
Increased
55
Reduced
44
Closed
25
Calls
$22.6M
Puts
$32.3M
Net Calls
-$9.66M
Net Calls Change
-$27.6M